A Study to Test the Safety and Antibody Response of V212 in Healthy Adults (V212-004)(COMPLETED)
Clinical trial NCT00696709 · COMPLETED
Trial details
- NCT number
- NCT00696709
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-12
- Primary completion
- 2009-11-16
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.